General Information of the Compound
Compound ID
CP0074960
Compound Name
2-((2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl)amino)-5,11-dimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one
    Show/Hide
Synonyms
XMD 8-92
XMD8-92
    Show/Hide
Structure
Formula
C26H30N6O3
Molecular Weight
474.565
Canonical SMILES
CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCC(O)CC1
    Show/Hide
InChI
InChI=1S/C26H30N6O3/c1-4-35-23-15-17(32-13-11-18(33)12-14-32)9-10-20(23)28-26-27-16-22-24(29-26)30(2)21-8-6-5-7-19(21)25(34)31(22)3/h5-10,15-16,18,33H,4,11-14H2,1-3H3,(H,27,28,29)
    Show/Hide
InChIKey
QAPAJIZPZGWAND-UHFFFAOYSA-N
Physicochemical Property
logP
3.9379
Rotatable Bonds
5
Heavy Atom Count
35
Polar Areas
94.06
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
8
Complexity
35

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 46843772
SID: 99230551
ChEMBL ID
CHEMBL1673046
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02105, Mitogen-activated protein kinase 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  2
1
IC50 = 240 nM
   TI
   LI
   LO
   TS
2
IC50 = 300 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 EC50 < 5000 nM
2 Kd = 80 nM
Clinical Information about the Compound
Drug 1 ( XMD8-92 )
Drug Name XMD8-92
Target(s)
Non-receptor tyrosine-protein kinase TNK1 (TNK1)
Inhibitor
Extracellular signal-regulated kinase 5 (ERK5)
Inhibitor
Polo-like kinase 4 (PLK4)
Inhibitor
Doublecortin-like kinase 2 (DCLK2)
Inhibitor